Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 575

1.

A Proximal Culture Method to Study Paracrine Signaling Between Cells.

Dasari S, Pandhiri T, Haley J, Lenz D, Mitra AK.

J Vis Exp. 2018 Aug 28;(138). doi: 10.3791/58144.

PMID:
30222146
2.

The phase problem for two-dimensional crystals. II. Simulations.

Arnal RD, Zhao Y, Mitra AK, Spence JCH, Millane RP.

Acta Crystallogr A Found Adv. 2018 Sep 1;74(Pt 5):537-544. doi: 10.1107/S2053273318008707. Epub 2018 Sep 1.

PMID:
30182940
3.

Corrigendum to "Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells" [Gyncol. Oncol. 144 (2017) 598-606].

Winterhoff BJ, Maile M, Mitra AK, Sebe A, Bazzaro M, Geller MA, Abrahante JE, Klein M, Hellweg R, Mullany SA, Beckman K, Daniel J, Starr TK.

Gynecol Oncol. 2018 Aug 7. pii: S0090-8258(18)31079-5. doi: 10.1016/j.ygyno.2018.07.015. [Epub ahead of print] No abstract available.

PMID:
30097329
4.

Factors associated with patients' satisfaction of rubber dam use during root canal treatment.

Maslamani M, Mitra AK.

Indian J Dent Res. 2018 Mar-Apr;29(2):144-149. doi: 10.4103/ijdr.IJDR_291_17.

5.

The relationship between outflow resistance and trabecular meshwork stiffness in mice.

Wang K, Li G, Read AT, Navarro I, Mitra AK, Stamer WD, Sulchek T, Ethier CR.

Sci Rep. 2018 Apr 11;8(1):5848. doi: 10.1038/s41598-018-24165-w.

6.

Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.

Ladanyi A, Mukherjee A, Kenny HA, Johnson A, Mitra AK, Sundaresan S, Nieman KM, Pascual G, Benitah SA, Montag A, Yamada SD, Abumrad NA, Lengyel E.

Oncogene. 2018 Apr;37(17):2285-2301. doi: 10.1038/s41388-017-0093-z. Epub 2018 Feb 5.

7.

Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.

Mandal A, Pal D, Agrahari V, Trinh HM, Joseph M, Mitra AK.

Adv Drug Deliv Rev. 2018 Feb 15;126:67-95. doi: 10.1016/j.addr.2018.01.008. Epub 2018 Jan 13. Review.

PMID:
29339145
8.

DNA Damage and Apoptosis Induction in Cancer Cells by Chemically Engineered Thiolated Riboflavin Gold Nanoassembly.

Sau A, Sanyal S, Bera K, Sen S, Mitra AK, Pal U, Chakraborty PK, Ganguly S, Satpati B, Das C, Basu S.

ACS Appl Mater Interfaces. 2018 Feb 7;10(5):4582-4589. doi: 10.1021/acsami.7b18837. Epub 2018 Jan 27.

PMID:
29338178
9.

Nanoparticles in thermosensitive gel based composite nanosystem for ocular diseases.

Agrahari V, Patel SP, Dhall N, Aulgur Z, Thukral S, Yang X, Conley R, Mitra AK.

Drug Deliv Transl Res. 2018 Apr;8(2):422-435. doi: 10.1007/s13346-017-0435-y.

PMID:
29181835
10.

ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinase.

Tomar S, Plotnik JP, Haley J, Scantland J, Dasari S, Sheikh Z, Emerson R, Lenz D, Hollenhorst PC, Mitra AK.

Cancer Lett. 2018 Feb 1;414:190-204. doi: 10.1016/j.canlet.2017.11.012. Epub 2017 Nov 22.

11.

Stoichiometry and mechanistic implications of the MacAB-TolC tripartite efflux pump.

Jo I, Hong S, Lee M, Song S, Kim JS, Mitra AK, Hyun J, Lee K, Ha NC.

Biochem Biophys Res Commun. 2017 Dec 16;494(3-4):668-673. doi: 10.1016/j.bbrc.2017.10.102. Epub 2017 Oct 20.

PMID:
29061301
12.

TORC1 organized in inhibited domains (TOROIDs) regulate TORC1 activity.

Prouteau M, Desfosses A, Sieben C, Bourgoint C, Lydia Mozaffari N, Demurtas D, Mitra AK, Guichard P, Manley S, Loewith R.

Nature. 2017 Oct 12;550(7675):265-269. doi: 10.1038/nature24021. Epub 2017 Oct 4.

13.

Synthetic peptides designed to modulate adiponectin assembly improve obesity-related metabolic disorders.

Hampe L, Xu C, Harris PWR, Chen J, Liu M, Middleditch M, Radjainia M, Wang Y, Mitra AK.

Br J Pharmacol. 2017 Dec;174(23):4478-4492. doi: 10.1111/bph.14050. Epub 2017 Nov 2.

PMID:
28945274
14.

Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.

Agrahari V, Aulgur Z, Thukral S, Dhall N, Conley R, Mitra AK.

Recent Pat Inflamm Allergy Drug Discov. 2017;11(2):92-106. doi: 10.2174/1872213X11666170913150146. Review.

PMID:
28901856
15.

Understanding the metal mediated assembly and hydrogel formation of a β-hairpin peptide.

De Leon-Rodriguez LM, Hemar Y, Mitra AK, Brimble MA.

Biomater Sci. 2017 Sep 26;5(10):1993-1997. doi: 10.1039/c7bm00512a.

PMID:
28853745
16.

Pentablock copolymer dexamethasone nanoformulations elevate MYOC: in vitro liberation, activity and safety in human trabecular meshwork cells.

Agrahari V, Li G, Agrahari V, Navarro I, Perkumas K, Mandal A, Stamer WD, Mitra AK.

Nanomedicine (Lond). 2017 Aug;12(16):1911-1926. doi: 10.2217/nnm-2017-0140. Epub 2017 Jul 31.

17.

A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma.

Mitra AK, Harding T, Mukherjee UK, Jang JS, Li Y, HongZheng R, Jen J, Sonneveld P, Kumar S, Kuehl WM, Rajkumar V, Van Ness B.

Blood Cancer J. 2017 Jun 30;7(6):e581. doi: 10.1038/bcj.2017.56.

18.

In vitro assembly of the Rous Sarcoma Virus capsid protein into hexamer tubes at physiological temperature.

Jaballah SA, Bailey GD, Desfosses A, Hyun J, Mitra AK, Kingston RL.

Sci Rep. 2017 Jun 6;7(1):2913. doi: 10.1038/s41598-017-02060-0.

19.

Topical Formulation of Self-Assembled Antiviral Prodrug Nanomicelles for Targeted Retinal Delivery.

Mandal A, Cholkar K, Khurana V, Shah A, Agrahari V, Bisht R, Pal D, Mitra AK.

Mol Pharm. 2017 Jun 5;14(6):2056-2069. doi: 10.1021/acs.molpharmaceut.7b00128. Epub 2017 May 17.

PMID:
28471177
20.

Constrained Photophysics of 5,7-dimethoxy-2,3,4,9-tetrahydro-1H-carbazol-1-one in the Bioenvironment of Serum Albumins: A Spectroscopic Endeavour Supported by Molecular Docking Analysis.

Mitra AK, Sau A, Pal U, Saha C, Basu S.

J Fluoresc. 2017 Jul;27(4):1547-1558. doi: 10.1007/s10895-017-2094-2. Epub 2017 Apr 22.

PMID:
28434063
21.

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells.

Thompson RM, Dytfeld D, Reyes L, Robinson RM, Smith B, Manevich Y, Jakubowiak A, Komarnicki M, Przybylowicz-Chalecka A, Szczepaniak T, Mitra AK, Van Ness BG, Luczak M, Dolloff NG.

Oncotarget. 2017 May 30;8(22):35863-35876. doi: 10.18632/oncotarget.16262.

22.

A de novo splice site mutation in EHMT1 resulting in Kleefstra syndrome with pharmacogenomics screening and behavior therapy for regressive behaviors.

Mitra AK, Dodge J, Van Ness J, Sokeye I, Van Ness B.

Mol Genet Genomic Med. 2016 Dec 26;5(2):130-140. doi: 10.1002/mgg3.265. eCollection 2017 Mar.

23.

Inner ear targeted drug delivery: what does the future hold?

Agrahari V, Agrahari V, Mitra AK.

Ther Deliv. 2017 Apr;8(4):179-184. doi: 10.4155/tde-2017-0001. No abstract available.

PMID:
28222657
24.

Prolactin Receptor-Mediated Internalization of Imaging Agents Detects Epithelial Ovarian Cancer with Enhanced Sensitivity and Specificity.

Sundaram KM, Zhang Y, Mitra AK, Kouadio JK, Gwin K, Kossiakoff AA, Roman BB, Lengyel E, Piccirilli JA.

Cancer Res. 2017 Apr 1;77(7):1684-1696. doi: 10.1158/0008-5472.CAN-16-1454. Epub 2017 Feb 15.

25.

Clear, Aqueous Topical Drop of Triamcinolone Acetonide.

Trinh HM, Cholkar K, Joseph M, Yang X, Mitra AK.

AAPS PharmSciTech. 2017 Oct;18(7):2466-2478. doi: 10.1208/s12249-017-0714-4. Epub 2017 Feb 9.

PMID:
28185211
26.

Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells.

Winterhoff BJ, Maile M, Mitra AK, Sebe A, Bazzaro M, Geller MA, Abrahante JE, Klein M, Hellweg R, Mullany SA, Beckman K, Daniel J, Starr TK.

Gynecol Oncol. 2017 Mar;144(3):598-606. doi: 10.1016/j.ygyno.2017.01.015. Epub 2017 Jan 19. Erratum in: Gynecol Oncol. 2018 Aug 7;:.

27.

Structural Model of the Tubular Assembly of the Rous Sarcoma Virus Capsid Protein.

Jeon J, Qiao X, Hung I, Mitra AK, Desfosses A, Huang D, Gor'kov PL, Craven RC, Kingston RL, Gan Z, Zhu F, Chen B.

J Am Chem Soc. 2017 Feb 8;139(5):2006-2013. doi: 10.1021/jacs.6b11939. Epub 2017 Jan 27.

PMID:
28094514
28.

Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.

Mandal A, Bisht R, Rupenthal ID, Mitra AK.

J Control Release. 2017 Feb 28;248:96-116. doi: 10.1016/j.jconrel.2017.01.012. Epub 2017 Jan 11. Review.

29.

Association of Quality of Coronal Filling with the Outcome of Endodontic Treatment: A Follow-up Study.

Maslamani M, Khalaf M, Mitra AK.

Dent J (Basel). 2017 Jan 11;5(1). pii: E5. doi: 10.3390/dj5010005.

30.

How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches.

Agrahari V, Agrahari V, Mandal A, Pal D, Mitra AK.

Expert Opin Drug Deliv. 2017 Oct;14(10):1145-1162. doi: 10.1080/17425247.2017.1272569. Epub 2016 Dec 28. Review.

PMID:
27967247
31.

A comprehensive insight on ocular pharmacokinetics.

Agrahari V, Mandal A, Agrahari V, Trinh HM, Joseph M, Ray A, Hadji H, Mitra R, Pal D, Mitra AK.

Drug Deliv Transl Res. 2016 Dec;6(6):735-754. Review.

32.

Next generation drug delivery: circulatory cells-mediated nanotherapeutic approaches.

Agrahari V, Agrahari V, Mitra AK.

Expert Opin Drug Deliv. 2017 Mar;14(3):285-289. doi: 10.1080/17425247.2017.1254614. Epub 2016 Nov 22. No abstract available.

PMID:
27791407
33.

Multifunctional thermoresponsive designer peptide hydrogels.

De Leon-Rodriguez LM, Hemar Y, Mo G, Mitra AK, Cornish J, Brimble MA.

Acta Biomater. 2017 Jan 1;47:40-49. doi: 10.1016/j.actbio.2016.10.014. Epub 2016 Oct 12.

PMID:
27744067
34.

Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells.

Yang X, Sheng Y, Ray A, Shah SJ, Trinh HM, Pal D, Mitra AK.

Drug Deliv. 2016 Sep;23(7):2532-2540. Epub 2015 Mar 16.

PMID:
25775276
35.

Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.

Yang X, Shah SJ, Wang Z, Agrahari V, Pal D, Mitra AK.

Drug Deliv. 2016 Sep;23(7):2399-2409. Epub 2015 Jan 7.

PMID:
25564964
36.

Recent perspectives on the delivery of biologics to back of the eye.

Joseph M, Trinh HM, Cholkar K, Pal D, Mitra AK.

Expert Opin Drug Deliv. 2017 May;14(5):631-645. doi: 10.1080/17425247.2016.1227783. Epub 2016 Sep 6. Review.

37.

Circumvention of P-gp and MRP2 mediated efflux of lopinavir by a histidine based dipeptide prodrug.

Mandal A, Pal D, Mitra AK.

Int J Pharm. 2016 Oct 15;512(1):49-60. doi: 10.1016/j.ijpharm.2016.08.027. Epub 2016 Aug 16.

38.

Transporter effects on cell permeability in drug delivery.

Mandal A, Agrahari V, Khurana V, Pal D, Mitra AK.

Expert Opin Drug Deliv. 2017 Mar;14(3):385-401. doi: 10.1080/17425247.2016.1214565. Epub 2016 Aug 5. Review.

PMID:
27449574
39.
40.

Corrigendum to "Topical delivery of aqueous micellar Resolvin E1 analog (RX-10045)" [Int. J. Pharm. 498 (2016) 326-334].

Cholkar K, Gilger BC, Mitra AK.

Int J Pharm. 2016 Jul 25;509(1-2):528. doi: 10.1016/j.ijpharm.2016.04.012. Epub 2016 Jun 28. No abstract available.

PMID:
27350413
41.

Fine-Mapping of 18q21.1 Locus Identifies Single Nucleotide Polymorphisms Associated with Nonsyndromic Cleft Lip with or without Cleft Palate.

Mitra AK, Stessman HA, Schaefer RJ, Wang W, Myers CL, Van Ness BG, Beiraghi S.

Front Genet. 2016 May 23;7:88. doi: 10.3389/fgene.2016.00088. eCollection 2016.

42.

Structures of Human Peroxiredoxin 3 Suggest Self-Chaperoning Assembly that Maintains Catalytic State.

Yewdall NA, Venugopal H, Desfosses A, Abrishami V, Yosaatmadja Y, Hampton MB, Gerrard JA, Goldstone DC, Mitra AK, Radjainia M.

Structure. 2016 Jul 6;24(7):1120-9. doi: 10.1016/j.str.2016.04.013. Epub 2016 May 26.

43.

Structural and Functional Analysis of the Allosteric Inhibition of IRE1α with ATP-Competitive Ligands.

Feldman HC, Tong M, Wang L, Meza-Acevedo R, Gobillot TA, Lebedev I, Gliedt MJ, Hari SB, Mitra AK, Backes BJ, Papa FR, Seeliger MA, Maly DJ.

ACS Chem Biol. 2016 Aug 19;11(8):2195-205. doi: 10.1021/acschembio.5b00940. Epub 2016 Jun 9.

44.

Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease.

Haley J, Tomar S, Pulliam N, Xiong S, Perkins SM, Karpf AR, Mitra S, Nephew KP, Mitra AK.

Oncotarget. 2016 May 31;7(22):32810-20. doi: 10.18632/oncotarget.9053.

45.

Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.

Agrahari V, Agrahari V, Mitra AK.

Ther Deliv. 2016;7(4):257-78. doi: 10.4155/tde-2015-0012. Review.

46.

A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas.

Mittal K, Choi DH, Klimov S, Pawar S, Kaur R, Mitra AK, Gupta MV, Sams R, Cantuaria G, Rida PCG, Aneja R.

J Ovarian Res. 2016 Mar 18;9:17. doi: 10.1186/s13048-016-0224-0.

47.

Optimization of novel pentablock copolymer based composite formulation for sustained delivery of peptide/protein in the treatment of ocular diseases.

Patel SP, Vaishya R, Patel A, Agrahari V, Pal D, Mitra AK.

J Microencapsul. 2016;33(2):103-13. doi: 10.3109/02652048.2015.1134685. Epub 2016 Mar 11.

48.

Uptake and Permeability Studies to Delineate the Role of Efflux Transporters.

Vadlapatla RK, Pal D, Mitra AK.

Methods Mol Biol. 2016;1395:69-74. doi: 10.1007/978-1-4939-3347-1_5.

PMID:
26910069
49.

A peptide hydrogel derived from a fragment of human cardiac troponin C.

De Leon-Rodriguez LM, Kamalov M, Hemar Y, Mitra AK, Castelletto V, Hermida-Merino D, Hamley IW, Brimble MA.

Chem Commun (Camb). 2016 Mar 14;52(21):4056-9. doi: 10.1039/c6cc00209a.

PMID:
26892840
50.

Erratum: Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.

Kenny HA, Lal-Nag M, White EA, Shen M, Chiang CY, Mitra AK, Zhang Y, Curtis M, Schryver EM, Bettis S, Jadhav A, Boxer MB, Li Z, Ferrer M, Lengyel E.

Nat Commun. 2016 Feb 3;7:10649. doi: 10.1038/ncomms10649. No abstract available.

Supplemental Content

Loading ...
Support Center